Enfusion
ENFN52
$10.76arrow_drop_down0.37%-$0.04
ENFN52
$10.76
arrow_drop_down0.37%| Key Stats | |
|---|---|
| Open | $10.76 |
| Prev. Close | $10.80 |
| EPS | 0.04 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 10.40 | 11.46 |
| 52 Week Range | 7.52 | 12.29 |
| Ratios | |
|---|---|
| EPS | 0.04 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
ENFN-
US Technology Sector-
US Market-
warning
ENFN / Market
ENFN lose to the US Market which returned 0.03% over the last twenty four hours.check_circle
ENFN / Technology Sector
ENFN matched the US Technology sector which returned -0.41% over the last twenty four hours.Enfusion (ENFN) Statistics
Keep an eye on Enfusion
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Enfusion (ENFN) stock's performance compared to its sector and the market over the past year?
Over the past year, Enfusion (ENFN) has experienced a price change of . Compared to the Technology sector, which saw a change of 15.12%, Enfusion has underperformed compared to its sector, indicating its relative standing within the Technology sector. Against the broader market's change of 21.40%, it has fallen short of the market average. This comparison highlights Enfusion's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Enfusion (ENFN) stock?
The PE (Price to Earnings) ratio of Enfusion (ENFN) is currently 269. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Enfusion (ENFN) stock?
The Earnings Per Share (EPS) for Enfusion (ENFN), calculated on a diluted basis, is $0.04. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Enfusion (ENFN) stock?
The operating margin for Enfusion (ENFN) is 5.83%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Enfusion (ENFN) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Enfusion (ENFN) is $18.73M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Enfusion (ENFN) have?
Enfusion (ENFN) has a total debt of $21.13M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$27.17M.